Clinical Trials

There are several clinical trials that are currently ongoing:

Indication

Phase

Treatment

More information at ClinicalTrials.gov

LCA1 / GUCY2D

1/2

Subretinal gene augmentation

NCT03920007

LCA5 / Lebercilin

1/2

Subretinal gene augmentation

NCT05616793

LCA10 / CEP290

1/2

Subretinal gene editing

NCT03872479

RP

3

Oral N-acetylcysteine

NCT05537220

XLRS 1/2 Subretinal gene augmentation NCT05878860